Investment Thesis
OSR Holdings faces a severe financial distress situation with catastrophic operating losses (-631% margin) on contracting revenue (-17.7% YoY), coupled with a critical liquidity crisis (current ratio 0.16x) that threatens the company's ability to meet short-term obligations. At a cash burn rate of -4.3M operating cash flow against only 1.7M in cash, the company has limited runway unless dramatic operational improvements materialize immediately.
Strengths
- Zero long-term debt provides solvency buffer
- Positive gross profit of 592.9K on revenue base
- Net losses improving 33.4% YoY and EPS improving 83.3% YoY, indicating potential trend reversal
Risks
- Critical liquidity crisis with current ratio of 0.16x - unable to cover current liabilities with current assets
- Operating losses of -18.3M on revenue of 2.9M indicate non-viable business model at current scale
- Negative operating cash flow of -4.3M with minimal cash position of 1.7M creates near-term insolvency risk
- Revenue declining 17.7% YoY suggests market rejection or demand collapse
- Extremely low gross margin of 20.4% for medical device sector limits pricing power and profitability potential
- No insider activity in 90 days may signal lack of confidence from management
Key Metrics to Watch
- Operating cash flow trend - must turn positive to avoid cash depletion
- Cash balance depletion rate - critical at -4.3M annual burn against 1.7M reserves
- Revenue stabilization and return to growth - currently in -17.7% decline
- Path to EBITDA and operating profitability - currently -631% operating margin
- Current ratio improvement - must exceed 1.0x to resolve liquidity crisis
Financial Metrics
Revenue
2.9M
Net Income
-18.0M
EPS (Diluted)
$-0.80
Free Cash Flow
-4.3M
Total Assets
171.2M
Cash
1.7M
Profitability Ratios
Gross Margin
20.4%
Operating Margin
-631.0%
Net Margin
-619.8%
ROE
-14.2%
ROA
-10.5%
FCF Margin
-149.0%
Balance Sheet & Liquidity
Current Ratio
0.16x
Quick Ratio
0.15x
Debt/Equity
0.00x
Debt/Assets
25.8%
Interest Coverage
-286,500.05x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-04-13T20:30:23.187230 |
Data as of: 2025-12-31 |
Powered by Claude AI